CD8A and B-cell chronic lymphocytic leukemia: In patients with CLL, it markedly increases CD4 + and CD8 + T cell numbers, decreases Treg/CD4 + T cell ratio, downregulates immunosuppressive CD200 and CD272 expression and decreases the production of immunosuppressive IL-10 production.